- This article was considered for deletion at Wikipedia on July 21 2016. This is a backup of Wikipedia:Able_Labs. All of its AfDs can be found at Wikipedia:Special:PrefixIndex/Wikipedia:Articles_for_deletion/Able_Labs, the first at Wikipedia:Wikipedia:Articles_for_deletion/Able_Labs.
- Wikipedia editors had multiple issues with this page:
- This article needs additional references for verification. Please help by adding citations to reliable sources. Unsourced material will not be challenged and removed. (March 2015)
- The topic of this article may not meet Wikipedia's general notability guideline. But, that doesn't mean someone has to… establish notability by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond its mere trivial mention. (March 2015)
Able Laboratories, Inc. was a developer and manufacturer of generic pharmaceutical products in tablet, capsule, liquid and suppository dosage forms. The pharmaceutical company was headquartered in Cranbury, New Jersey.
In May 2005, Able suspended manufacturing and distribution of its entire product line, following a recall of all products produced by the company. The reason for the recall, as stated by the U.S. Food and Drug Administration (FDA), was "serious concerns" that the pharmaceuticals made by Able were not produced in accordance with acceptable quality standards. The company filed a petition to reorganize under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of New Jersey, Trenton Division on July 18, 2005.
The intellectual property and assets of Able Labs was purchased by Sun Pharmaceuticals of Mumbai, India in December 2005. In 2005, Sun also purchased a plant in Bryan, Ohio and the business of ICN, Hungary from Valeant Pharmaceuticals.